The page outlines how the company assists global and local pharmaceutical firms in navigating the regulatory requirements set by ANVISA (Agência Nacional de Vigilância Sanitária). Key services described include:

End-to-End Drug Registration: Support for new drugs, generics, biologics, and "similar" products.

Local Representation: Providing Brazilian Registration Holder (BRH) support for foreign companies.

Dossier Management: Preparation and submission of registration dossiers (CTD/eCTD formats) and gap analysis.

Lifecycle Management: Handling post-approval needs such as renewals, variations, and compliance monitoring.

Strategic Consulting: Guidance on priority review pathways, GMP certification support, and regulatory intelligence.

Essentially, the page positions DDReg as a specialized consultancy that helps companies manage the technical and legal complexities of entering and maintaining a presence in the Brazilian pharmaceutical market.